CompareMarketResearchRequest a sample
Home / Healthcare / Catheter-Directed Thrombolysis

Healthcare · Market report

Catheter-Directed Thrombolysis Market Size, Share and Forecast 2026-2036

The global catheter-directed thrombolysis market is worth USD 452 mn in 2026 and is forecast to reach USD 931 mn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Standard infusion catheters is the largest by device segment.

USD 452 mnMarket size 2026
USD 931 mnForecast 2036
7.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global catheter-directed thrombolysis market is worth USD 452 mn in 2026 and is forecast to reach USD 931 mn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Standard infusion catheters is the largest by device segment.

ScopeCatheters that deliver clot-dissolving drugs directly into blocked veins and arteries: ultrasound-assisted systems, multi-sidehole infusion catheters and pharmacomechanical devices for pulmonary embolism, deep vein thrombosis and arterial occlusion.
IndustryHealthcare
Value 2025USD 420 mn
Value 2026USD 452 mn
Value 2036USD 931 mn
CAGR 2026-20367.5%
Volume 2026118 thousand catheters
Volume 2036231 thousand catheters
Average price 2026USD 3,837 per catheter
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Catheter-Directed Thrombolysis market size and forecast, 2026-2036

Exhibit 1The global catheter-directed thrombolysis market is forecast to grow from USD 452 mn in 2026 to USD 931 mn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 7.5%
Catheter-Directed Thrombolysis market value, 2025 to 2036Market value by year. 2025: USD 420 mn; 2026: USD 452 mn; 2027: USD 485 mn; 2028: USD 522 mn; 2029: USD 561 mn; 2030: USD 603 mn; 2031: USD 648 mn; 2032: USD 697 mn; 2033: USD 749 mn; 2034: USD 805 mn; 2035: USD 866 mn; 2036: USD 931 mn. Compound annual growth rate 2026 to 2036: 7.5%.2025452 mn2026648 mn2031931 mn20367.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 452 mn
2027USD 485 mn
2028USD 522 mn
2029USD 561 mn
2030USD 603 mn
2031USD 648 mn
2032USD 697 mn
2033USD 749 mn
2034USD 805 mn
2035USD 866 mn
2036USD 931 mn

Catheter-Directed Thrombolysis market segmentation

By device

Exhibit 2Standard infusion catheters is the largest segment by device, with 46.0% of 2026 revenueEstimated share of 2026 global revenue, by device
Catheter-Directed Thrombolysis market share by device, 2026Share of 2026 revenue by device. Standard infusion catheters: 46.0%; Ultrasound-assisted systems: 38.0%; Pharmacomechanical devices: 16.0%.Standard infusion catheters46.0%Ultrasound-assisted systems38.0%Pharmacomechanical devices16.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Standard infusion catheters46.0%37.0%USD 208 mn5.2%
Ultrasound-assisted systems38.0%42.5%USD 172 mn8.7%
Pharmacomechanical devices16.0%20.5%USD 72 mn10.2%

By indication

Exhibit 3Pulmonary embolism adds the most revenue by indication, growing from USD 181 mn in 2026 to USD 434 mn by 2036Estimated revenue in USD by indication, 2026 and 2036 forecast
Catheter-Directed Thrombolysis market by indication, 2026 and 2036Revenue by indication in 2026 and 2036. Pulmonary embolism: USD 181 mn in 2026, USD 434 mn in 2036, change +140%; Deep vein thrombosis: USD 172 mn in 2026, USD 327 mn in 2036, change +90%; Peripheral arterial occlusion: USD 72 mn in 2026, USD 125 mn in 2036, change +73%; Other: USD 27 mn in 2026, USD 45 mn in 2036, change +65%.20262036 forecastChangePulmonary embolism+140%181 mn434 mnDeep vein thrombosis+90%172 mn327 mnPeripheral arterial occlusion+73%72 mn125 mnOther+65%27 mn45 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Pulmonary embolism40.0%46.6%USD 181 mn9.2%
Deep vein thrombosis38.0%35.1%USD 172 mn6.7%
Peripheral arterial occlusion16.0%13.5%USD 72 mn5.7%
Other6.0%4.8%USD 27 mn5.2%

By technique

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Ultrasound-assisted36.0%38.0%USD 163 mn8.1%
Pharmaco-mechanical34.0%32.0%USD 154 mn6.8%
Standard catheter30.0%30.0%USD 135 mn7.5%

By vessel

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Deep vein thrombosis50.0%46.0%USD 226 mn6.6%
Pulmonary embolism32.0%35.0%USD 144 mn8.5%
Arterial18.0%19.0%USD 81 mn8.1%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals62.0%58.0%USD 280 mn6.8%
Specialty vascular centers24.0%26.0%USD 108 mn8.4%
Ambulatory surgery centers14.0%16.0%USD 63 mn8.9%

Top 25 countries for catheter-directed thrombolysis by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 87.0% of 2026 revenue and the 25 countries below together hold 96.0%.

Exhibit 4United States is the largest country market at USD 235 mn in 2026, and the three largest countries hold 64.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Catheter-Directed Thrombolysis market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 235 mn, 52.0%; China: USD 27 mn, 6.0%; Germany: USD 27 mn, 6.0%; Japan: USD 23 mn, 5.0%; France: USD 18 mn, 4.0%; United Kingdom: USD 18 mn, 4.0%; Italy: USD 14 mn, 3.0%; Canada: USD 14 mn, 3.0%; Spain: USD 9.0 mn, 2.0%; Australia: USD 9.0 mn, 2.0%.United States235 mn 52.0%China27 mn 6.0%Germany27 mn 6.0%Japan23 mn 5.0%France18 mn 4.0%United Kingdom18 mn 4.0%Italy14 mn 3.0%Canada14 mn 3.0%Spain9.0 mn 2.0%Australia9.0 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 235 mn52.0%USD 489 mn7.6%
2ChinaUSD 27 mn6.0%USD 68 mn9.6%
3GermanyUSD 27 mn6.0%USD 51 mn6.6%
4JapanUSD 23 mn5.0%USD 41 mn6.1%
5FranceUSD 18 mn4.0%USD 34 mn6.7%
6United KingdomUSD 18 mn4.0%USD 36 mn7.2%
7ItalyUSD 14 mn3.0%USD 24 mn6.0%
8CanadaUSD 14 mn3.0%USD 27 mn7.1%
9SpainUSD 9.0 mn2.0%USD 17 mn6.4%
10AustraliaUSD 9.0 mn2.0%USD 19 mn7.5%
11South KoreaUSD 5.9 mn1.3%USD 13 mn8.4%
12NetherlandsUSD 5.9 mn1.3%USD 12 mn7.2%
13BrazilUSD 4.7 mn1.0%USD 10 mn8.3%
14IndiaUSD 4.2 mn0.9%USD 9.6 mn8.5%
15SwitzerlandUSD 3.9 mn0.9%USD 7.8 mn7.2%
16BelgiumUSD 2.8 mn0.6%USD 5.7 mn7.2%
17SwedenUSD 2.2 mn0.5%USD 4.5 mn7.3%
18AustriaUSD 2.2 mn0.5%USD 4.4 mn7.0%
19MexicoUSD 2.0 mn0.5%USD 4.6 mn8.4%
20PolandUSD 1.7 mn0.4%USD 3.9 mn8.6%
21TaiwanUSD 1.5 mn0.3%USD 3.3 mn8.1%
22IsraelUSD 1.1 mn0.2%USD 2.1 mn7.0%
23DenmarkUSD 0.86 mn0.2%USD 1.7 mn6.9%
24Saudi ArabiaUSD 0.86 mn0.2%USD 1.9 mn8.1%
25SingaporeUSD 0.68 mn0.1%USD 1.5 mn8.2%
Rest of worldUSD 18 mn4.0%USD 38 mn7.6%
Exhibit 5United States and China account for 62% of the USD 479 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Catheter-Directed Thrombolysis market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 452 mn. United States: +USD 255 mn; China: +USD 41 mn; Germany: +USD 24 mn; Japan: +USD 18 mn; United Kingdom: +USD 18 mn; 20 other countries: +USD 103 mn; Rest of world: +USD 20 mn. Market value 2036: USD 931 mn.Market value 2026452 mnUnited States+255 mnChina+41 mnGermany+24 mnJapan+18 mnUnited Kingdom+18 mn20 other countries+103 mnRest of world+20 mnMarket value 2036931 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Boston Scientific
  • Cook Medical
  • Merit Medical

Group 2: Regional and specialist players

  • AngioDynamics
  • Argon Medical
  • Penumbra
  • Medtronic

Group 3: Emerging and niche players

  • Thrombolex

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the catheter-directed thrombolysis market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.

The market is divided by device, by indication, by technique, by vessel, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the catheter-directed thrombolysis market?

The global catheter-directed thrombolysis market is estimated at USD 420 mn in 2025 and USD 452 mn in 2026.

How fast will the catheter-directed thrombolysis market grow?

It is forecast to reach USD 931 mn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 479 mn.

Which country is the largest market for catheter-directed thrombolysis?

United States is the largest market by revenue at USD 235 mn in 2026, 52.0% of the global total. The three largest countries together hold 64.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 9.6% a year from 2026 to 2036.

Which catheter-directed thrombolysis segment is largest?

In the by device split, Standard infusion catheters is the largest segment with 46.0% of 2026 revenue.

Who are the leading catheter-directed thrombolysis companies?

Global leaders include Boston Scientific, Cook Medical, Merit Medical.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Catheter-Based Pulmonary Embolism Thrombectomy Cell Culture →

All Healthcare markets →

Request a sample